BOCA RATON, Fla., April 30, 2013 /PRNewswire/ -- Sensus Healthcare is proud to announce their exhibitor participation in the 45th American College of Mohs Surgery in Washington, D.C. on May 2-5, 2013. Visit booth #310 to learn more about the advanced SRT-100™ superficial radiotherapy platform, featuring SharpBeam™. The SRT-100 offers unique features and benefits providing Dermatologists with a cost effective, non-invasive option for treating their patients who are diagnosed with skin cancer!
We cordially invite all ACMS attendees to visit our booth (#310) at the upcoming 45th ACMS Annual Meeting in Washington, D.C. and rediscover superficial radiotherapy (SRT). We are proud to feature our SRT-100™; non-invasive treatment system and demonstrate the impact it can have on your practice by providing your patients with a non-invasive treatment option while at the same time increasing your productivity and realizing an excellent ROI! "Superficial Radiotherapy (SRT) is a cost effective alternative to surgery while having the same cure rates. Having SRT in your practice provides the Mohs Surgeon with a Total Solutions approach to treating NMSC," stated Joe Sardano, President/CEO, Sensus Healthcare.
See you in Washington!
About Sensus Healthcare: Sensus Healthcare is the worldwide leader dedicated to Superficial Radiotherapy Technology (SRT). The featured SRT-100 System is the most advanced non-invasive technology used by Dermatologists and Radiation Oncologists throughout the world in treating Basal Cell (BCC) and Squamous Cell (SCC) Carcinomas. The SRT-100 features SharpBeam technology providing the most accurate and safest treatment possible resulting in proven outcomes. Visit our web site to learn more about Sensus Healthcare..............Taking new aim at treating skin cancer! www.sensushealthcare.com
Media Contact: Michelle Verina Public Relations 561-922-5808 Ext. 100 [email protected]